Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's dise...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lancet neurology 2017-08, Vol.16 (8), p.661-676
Hauptverfasser: Frisoni, Giovanni B, Boccardi, Marina, Barkhof, Frederik, Blennow, Kaj, Cappa, Stefano, Chiotis, Konstantinos, Démonet, Jean-Francois, Garibotto, Valentina, Giannakopoulos, Panteleimon, Gietl, Anton, Hansson, Oskar, Herholz, Karl, Jack, Clifford R, Nobili, Flavio, Nordberg, Agneta, Snyder, Heather M, Ten Kate, Mara, Varrone, Andrea, Albanese, Emiliano, Becker, Stefanie, Bossuyt, Patrick, Carrillo, Maria C, Cerami, Chiara, Dubois, Bruno, Gallo, Valentina, Giacobini, Ezio, Gold, Gabriel, Hurst, Samia, Lönneborg, Anders, Lovblad, Karl-Olof, Mattsson, Niklas, Molinuevo, José-Luis, Monsch, Andreas U, Mosimann, Urs, Padovani, Alessandro, Picco, Agnese, Porteri, Corinna, Ratib, Osman, Saint-Aubert, Laure, Scerri, Charles, Scheltens, Philip, Schott, Jonathan M, Sonni, Ida, Teipel, Stefan, Vineis, Paolo, Visser, Pieter Jelle, Yasui, Yutaka, Winblad, Bengt
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 676
container_issue 8
container_start_page 661
container_title Lancet neurology
container_volume 16
creator Frisoni, Giovanni B
Boccardi, Marina
Barkhof, Frederik
Blennow, Kaj
Cappa, Stefano
Chiotis, Konstantinos
Démonet, Jean-Francois
Garibotto, Valentina
Giannakopoulos, Panteleimon
Gietl, Anton
Hansson, Oskar
Herholz, Karl
Jack, Clifford R
Nobili, Flavio
Nordberg, Agneta
Snyder, Heather M
Ten Kate, Mara
Varrone, Andrea
Albanese, Emiliano
Becker, Stefanie
Bossuyt, Patrick
Carrillo, Maria C
Cerami, Chiara
Dubois, Bruno
Gallo, Valentina
Giacobini, Ezio
Gold, Gabriel
Hurst, Samia
Lönneborg, Anders
Lovblad, Karl-Olof
Mattsson, Niklas
Molinuevo, José-Luis
Monsch, Andreas U
Mosimann, Urs
Padovani, Alessandro
Picco, Agnese
Porteri, Corinna
Ratib, Osman
Saint-Aubert, Laure
Scerri, Charles
Scheltens, Philip
Schott, Jonathan M
Sonni, Ida
Teipel, Stefan
Vineis, Paolo
Visser, Pieter Jelle
Yasui, Yutaka
Winblad, Bengt
description The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings. However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care. We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers. Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete. To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.
doi_str_mv 10.1016/S1474-4422(17)30159-X
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_495341</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S147444221730159X</els_id><sourcerecordid>1920395361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c703t-548509a490014835d1dbdfa3bb526e8b11ce37eda29d0f2347207249162ddef83</originalsourceid><addsrcrecordid>eNqFkstu1TAQhiMEoqXwCCBLLCiLgMex42SFqqpcpCOxOCB1Z_kyObhN4mAnoPbp8blwFkjAwvZo_M3ML_sviudA3wCF-u0auOQl54ydg3xdURBtef2gOD2ka_HwGDN2UjxJ6YZSBryBx8UJaySDljWnxXo9Rz3jxlsSg3aDnkgXItEjQR37O-K83owh-URCRy76-2_oB4yvUr5IqBMSkzdHwkiMD4OOtxjT0-JRp_uEzw7nWfH1_dWXy4_l6vOHT5cXq9JKWs2l4I2greYtpVlWJRw44zpdGSNYjY0BsFhJdJq1jnas4pJRyXgLNXMOu6Y6K8p93_QTp8WoKfqs4E4F7dUhdZsjVLwVFYfMr_7K98uUl8lrWwBcMNFaUJppq7isUZk8VTlaUWwQGinbf47f5HY5tdl1Y0LUUmb-fM9PMXxfMM1q8Mli3-sRw5JU_hBaZaX1VunLP9CbsMQxP2amoOUCOBWZEnvKxpBSxO4oAajamkTtTKK2DlAg1c4k6jrXvTh0X8yA7lj12xUZeLcHMP_eD49RJetxtOh8RDsrF_x_RvwC5gXLIw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1919451405</pqid></control><display><type>article</type><title>Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Frisoni, Giovanni B ; Boccardi, Marina ; Barkhof, Frederik ; Blennow, Kaj ; Cappa, Stefano ; Chiotis, Konstantinos ; Démonet, Jean-Francois ; Garibotto, Valentina ; Giannakopoulos, Panteleimon ; Gietl, Anton ; Hansson, Oskar ; Herholz, Karl ; Jack, Clifford R ; Nobili, Flavio ; Nordberg, Agneta ; Snyder, Heather M ; Ten Kate, Mara ; Varrone, Andrea ; Albanese, Emiliano ; Becker, Stefanie ; Bossuyt, Patrick ; Carrillo, Maria C ; Cerami, Chiara ; Dubois, Bruno ; Gallo, Valentina ; Giacobini, Ezio ; Gold, Gabriel ; Hurst, Samia ; Lönneborg, Anders ; Lovblad, Karl-Olof ; Mattsson, Niklas ; Molinuevo, José-Luis ; Monsch, Andreas U ; Mosimann, Urs ; Padovani, Alessandro ; Picco, Agnese ; Porteri, Corinna ; Ratib, Osman ; Saint-Aubert, Laure ; Scerri, Charles ; Scheltens, Philip ; Schott, Jonathan M ; Sonni, Ida ; Teipel, Stefan ; Vineis, Paolo ; Visser, Pieter Jelle ; Yasui, Yutaka ; Winblad, Bengt</creator><creatorcontrib>Frisoni, Giovanni B ; Boccardi, Marina ; Barkhof, Frederik ; Blennow, Kaj ; Cappa, Stefano ; Chiotis, Konstantinos ; Démonet, Jean-Francois ; Garibotto, Valentina ; Giannakopoulos, Panteleimon ; Gietl, Anton ; Hansson, Oskar ; Herholz, Karl ; Jack, Clifford R ; Nobili, Flavio ; Nordberg, Agneta ; Snyder, Heather M ; Ten Kate, Mara ; Varrone, Andrea ; Albanese, Emiliano ; Becker, Stefanie ; Bossuyt, Patrick ; Carrillo, Maria C ; Cerami, Chiara ; Dubois, Bruno ; Gallo, Valentina ; Giacobini, Ezio ; Gold, Gabriel ; Hurst, Samia ; Lönneborg, Anders ; Lovblad, Karl-Olof ; Mattsson, Niklas ; Molinuevo, José-Luis ; Monsch, Andreas U ; Mosimann, Urs ; Padovani, Alessandro ; Picco, Agnese ; Porteri, Corinna ; Ratib, Osman ; Saint-Aubert, Laure ; Scerri, Charles ; Scheltens, Philip ; Schott, Jonathan M ; Sonni, Ida ; Teipel, Stefan ; Vineis, Paolo ; Visser, Pieter Jelle ; Yasui, Yutaka ; Winblad, Bengt</creatorcontrib><description>The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings. However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care. We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers. Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete. To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(17)30159-X</identifier><identifier>PMID: 28721928</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>1984 ; 1992 ; 5-phase development framework ; Algorithms ; Alzheimer Disease - diagnosis ; Alzheimer's disease ; amyloid pet ; association workgroups ; Biomarkers ; Brain research ; Cancer ; Cerebrospinal fluid ; cerebrospinal-fluid biomarkers ; clinical ; Clinical Medicine ; Clinical trials ; Cognitive ability ; Dementia ; Diagnosis ; Early Diagnosis ; heltens p ; Humans ; Interdisciplinary aspects ; journal of neurology neurosurgery and psychiatry ; khann g ; Klinisk medicin ; Magnetic resonance imaging ; Medical and Health Sciences ; Medical diagnosis ; Medical imaging ; Medicin och hälsovetenskap ; mild cognitive impairment ; national institute ; Neurodegenerative diseases ; Neuroimaging ; Neurologi ; Neurology ; Neurosciences &amp; Neurology ; p939 ; p967 ; Physicians ; Positron emission tomography ; Regulatory approval ; Task forces ; task-force ; tau pathology ; v34 ; v55 ; Validation Studies as Topic ; Validity</subject><ispartof>Lancet neurology, 2017-08, Vol.16 (8), p.661-676</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 1, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c703t-548509a490014835d1dbdfa3bb526e8b11ce37eda29d0f2347207249162ddef83</citedby><cites>FETCH-LOGICAL-c703t-548509a490014835d1dbdfa3bb526e8b11ce37eda29d0f2347207249162ddef83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S147444221730159X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28721928$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/255677$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/145259c1-a2ac-476e-b62d-d030e8e18779$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:136182913$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Frisoni, Giovanni B</creatorcontrib><creatorcontrib>Boccardi, Marina</creatorcontrib><creatorcontrib>Barkhof, Frederik</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Cappa, Stefano</creatorcontrib><creatorcontrib>Chiotis, Konstantinos</creatorcontrib><creatorcontrib>Démonet, Jean-Francois</creatorcontrib><creatorcontrib>Garibotto, Valentina</creatorcontrib><creatorcontrib>Giannakopoulos, Panteleimon</creatorcontrib><creatorcontrib>Gietl, Anton</creatorcontrib><creatorcontrib>Hansson, Oskar</creatorcontrib><creatorcontrib>Herholz, Karl</creatorcontrib><creatorcontrib>Jack, Clifford R</creatorcontrib><creatorcontrib>Nobili, Flavio</creatorcontrib><creatorcontrib>Nordberg, Agneta</creatorcontrib><creatorcontrib>Snyder, Heather M</creatorcontrib><creatorcontrib>Ten Kate, Mara</creatorcontrib><creatorcontrib>Varrone, Andrea</creatorcontrib><creatorcontrib>Albanese, Emiliano</creatorcontrib><creatorcontrib>Becker, Stefanie</creatorcontrib><creatorcontrib>Bossuyt, Patrick</creatorcontrib><creatorcontrib>Carrillo, Maria C</creatorcontrib><creatorcontrib>Cerami, Chiara</creatorcontrib><creatorcontrib>Dubois, Bruno</creatorcontrib><creatorcontrib>Gallo, Valentina</creatorcontrib><creatorcontrib>Giacobini, Ezio</creatorcontrib><creatorcontrib>Gold, Gabriel</creatorcontrib><creatorcontrib>Hurst, Samia</creatorcontrib><creatorcontrib>Lönneborg, Anders</creatorcontrib><creatorcontrib>Lovblad, Karl-Olof</creatorcontrib><creatorcontrib>Mattsson, Niklas</creatorcontrib><creatorcontrib>Molinuevo, José-Luis</creatorcontrib><creatorcontrib>Monsch, Andreas U</creatorcontrib><creatorcontrib>Mosimann, Urs</creatorcontrib><creatorcontrib>Padovani, Alessandro</creatorcontrib><creatorcontrib>Picco, Agnese</creatorcontrib><creatorcontrib>Porteri, Corinna</creatorcontrib><creatorcontrib>Ratib, Osman</creatorcontrib><creatorcontrib>Saint-Aubert, Laure</creatorcontrib><creatorcontrib>Scerri, Charles</creatorcontrib><creatorcontrib>Scheltens, Philip</creatorcontrib><creatorcontrib>Schott, Jonathan M</creatorcontrib><creatorcontrib>Sonni, Ida</creatorcontrib><creatorcontrib>Teipel, Stefan</creatorcontrib><creatorcontrib>Vineis, Paolo</creatorcontrib><creatorcontrib>Visser, Pieter Jelle</creatorcontrib><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Winblad, Bengt</creatorcontrib><title>Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings. However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care. We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers. Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete. To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.</description><subject>1984</subject><subject>1992</subject><subject>5-phase development framework</subject><subject>Algorithms</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer's disease</subject><subject>amyloid pet</subject><subject>association workgroups</subject><subject>Biomarkers</subject><subject>Brain research</subject><subject>Cancer</subject><subject>Cerebrospinal fluid</subject><subject>cerebrospinal-fluid biomarkers</subject><subject>clinical</subject><subject>Clinical Medicine</subject><subject>Clinical trials</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Diagnosis</subject><subject>Early Diagnosis</subject><subject>heltens p</subject><subject>Humans</subject><subject>Interdisciplinary aspects</subject><subject>journal of neurology neurosurgery and psychiatry</subject><subject>khann g</subject><subject>Klinisk medicin</subject><subject>Magnetic resonance imaging</subject><subject>Medical and Health Sciences</subject><subject>Medical diagnosis</subject><subject>Medical imaging</subject><subject>Medicin och hälsovetenskap</subject><subject>mild cognitive impairment</subject><subject>national institute</subject><subject>Neurodegenerative diseases</subject><subject>Neuroimaging</subject><subject>Neurologi</subject><subject>Neurology</subject><subject>Neurosciences &amp; Neurology</subject><subject>p939</subject><subject>p967</subject><subject>Physicians</subject><subject>Positron emission tomography</subject><subject>Regulatory approval</subject><subject>Task forces</subject><subject>task-force</subject><subject>tau pathology</subject><subject>v34</subject><subject>v55</subject><subject>Validation Studies as Topic</subject><subject>Validity</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkstu1TAQhiMEoqXwCCBLLCiLgMex42SFqqpcpCOxOCB1Z_kyObhN4mAnoPbp8blwFkjAwvZo_M3ML_sviudA3wCF-u0auOQl54ydg3xdURBtef2gOD2ka_HwGDN2UjxJ6YZSBryBx8UJaySDljWnxXo9Rz3jxlsSg3aDnkgXItEjQR37O-K83owh-URCRy76-2_oB4yvUr5IqBMSkzdHwkiMD4OOtxjT0-JRp_uEzw7nWfH1_dWXy4_l6vOHT5cXq9JKWs2l4I2greYtpVlWJRw44zpdGSNYjY0BsFhJdJq1jnas4pJRyXgLNXMOu6Y6K8p93_QTp8WoKfqs4E4F7dUhdZsjVLwVFYfMr_7K98uUl8lrWwBcMNFaUJppq7isUZk8VTlaUWwQGinbf47f5HY5tdl1Y0LUUmb-fM9PMXxfMM1q8Mli3-sRw5JU_hBaZaX1VunLP9CbsMQxP2amoOUCOBWZEnvKxpBSxO4oAajamkTtTKK2DlAg1c4k6jrXvTh0X8yA7lj12xUZeLcHMP_eD49RJetxtOh8RDsrF_x_RvwC5gXLIw</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Frisoni, Giovanni B</creator><creator>Boccardi, Marina</creator><creator>Barkhof, Frederik</creator><creator>Blennow, Kaj</creator><creator>Cappa, Stefano</creator><creator>Chiotis, Konstantinos</creator><creator>Démonet, Jean-Francois</creator><creator>Garibotto, Valentina</creator><creator>Giannakopoulos, Panteleimon</creator><creator>Gietl, Anton</creator><creator>Hansson, Oskar</creator><creator>Herholz, Karl</creator><creator>Jack, Clifford R</creator><creator>Nobili, Flavio</creator><creator>Nordberg, Agneta</creator><creator>Snyder, Heather M</creator><creator>Ten Kate, Mara</creator><creator>Varrone, Andrea</creator><creator>Albanese, Emiliano</creator><creator>Becker, Stefanie</creator><creator>Bossuyt, Patrick</creator><creator>Carrillo, Maria C</creator><creator>Cerami, Chiara</creator><creator>Dubois, Bruno</creator><creator>Gallo, Valentina</creator><creator>Giacobini, Ezio</creator><creator>Gold, Gabriel</creator><creator>Hurst, Samia</creator><creator>Lönneborg, Anders</creator><creator>Lovblad, Karl-Olof</creator><creator>Mattsson, Niklas</creator><creator>Molinuevo, José-Luis</creator><creator>Monsch, Andreas U</creator><creator>Mosimann, Urs</creator><creator>Padovani, Alessandro</creator><creator>Picco, Agnese</creator><creator>Porteri, Corinna</creator><creator>Ratib, Osman</creator><creator>Saint-Aubert, Laure</creator><creator>Scerri, Charles</creator><creator>Scheltens, Philip</creator><creator>Schott, Jonathan M</creator><creator>Sonni, Ida</creator><creator>Teipel, Stefan</creator><creator>Vineis, Paolo</creator><creator>Visser, Pieter Jelle</creator><creator>Yasui, Yutaka</creator><creator>Winblad, Bengt</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope><scope>D95</scope></search><sort><creationdate>20170801</creationdate><title>Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</title><author>Frisoni, Giovanni B ; Boccardi, Marina ; Barkhof, Frederik ; Blennow, Kaj ; Cappa, Stefano ; Chiotis, Konstantinos ; Démonet, Jean-Francois ; Garibotto, Valentina ; Giannakopoulos, Panteleimon ; Gietl, Anton ; Hansson, Oskar ; Herholz, Karl ; Jack, Clifford R ; Nobili, Flavio ; Nordberg, Agneta ; Snyder, Heather M ; Ten Kate, Mara ; Varrone, Andrea ; Albanese, Emiliano ; Becker, Stefanie ; Bossuyt, Patrick ; Carrillo, Maria C ; Cerami, Chiara ; Dubois, Bruno ; Gallo, Valentina ; Giacobini, Ezio ; Gold, Gabriel ; Hurst, Samia ; Lönneborg, Anders ; Lovblad, Karl-Olof ; Mattsson, Niklas ; Molinuevo, José-Luis ; Monsch, Andreas U ; Mosimann, Urs ; Padovani, Alessandro ; Picco, Agnese ; Porteri, Corinna ; Ratib, Osman ; Saint-Aubert, Laure ; Scerri, Charles ; Scheltens, Philip ; Schott, Jonathan M ; Sonni, Ida ; Teipel, Stefan ; Vineis, Paolo ; Visser, Pieter Jelle ; Yasui, Yutaka ; Winblad, Bengt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c703t-548509a490014835d1dbdfa3bb526e8b11ce37eda29d0f2347207249162ddef83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>1984</topic><topic>1992</topic><topic>5-phase development framework</topic><topic>Algorithms</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer's disease</topic><topic>amyloid pet</topic><topic>association workgroups</topic><topic>Biomarkers</topic><topic>Brain research</topic><topic>Cancer</topic><topic>Cerebrospinal fluid</topic><topic>cerebrospinal-fluid biomarkers</topic><topic>clinical</topic><topic>Clinical Medicine</topic><topic>Clinical trials</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Diagnosis</topic><topic>Early Diagnosis</topic><topic>heltens p</topic><topic>Humans</topic><topic>Interdisciplinary aspects</topic><topic>journal of neurology neurosurgery and psychiatry</topic><topic>khann g</topic><topic>Klinisk medicin</topic><topic>Magnetic resonance imaging</topic><topic>Medical and Health Sciences</topic><topic>Medical diagnosis</topic><topic>Medical imaging</topic><topic>Medicin och hälsovetenskap</topic><topic>mild cognitive impairment</topic><topic>national institute</topic><topic>Neurodegenerative diseases</topic><topic>Neuroimaging</topic><topic>Neurologi</topic><topic>Neurology</topic><topic>Neurosciences &amp; Neurology</topic><topic>p939</topic><topic>p967</topic><topic>Physicians</topic><topic>Positron emission tomography</topic><topic>Regulatory approval</topic><topic>Task forces</topic><topic>task-force</topic><topic>tau pathology</topic><topic>v34</topic><topic>v55</topic><topic>Validation Studies as Topic</topic><topic>Validity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Frisoni, Giovanni B</creatorcontrib><creatorcontrib>Boccardi, Marina</creatorcontrib><creatorcontrib>Barkhof, Frederik</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Cappa, Stefano</creatorcontrib><creatorcontrib>Chiotis, Konstantinos</creatorcontrib><creatorcontrib>Démonet, Jean-Francois</creatorcontrib><creatorcontrib>Garibotto, Valentina</creatorcontrib><creatorcontrib>Giannakopoulos, Panteleimon</creatorcontrib><creatorcontrib>Gietl, Anton</creatorcontrib><creatorcontrib>Hansson, Oskar</creatorcontrib><creatorcontrib>Herholz, Karl</creatorcontrib><creatorcontrib>Jack, Clifford R</creatorcontrib><creatorcontrib>Nobili, Flavio</creatorcontrib><creatorcontrib>Nordberg, Agneta</creatorcontrib><creatorcontrib>Snyder, Heather M</creatorcontrib><creatorcontrib>Ten Kate, Mara</creatorcontrib><creatorcontrib>Varrone, Andrea</creatorcontrib><creatorcontrib>Albanese, Emiliano</creatorcontrib><creatorcontrib>Becker, Stefanie</creatorcontrib><creatorcontrib>Bossuyt, Patrick</creatorcontrib><creatorcontrib>Carrillo, Maria C</creatorcontrib><creatorcontrib>Cerami, Chiara</creatorcontrib><creatorcontrib>Dubois, Bruno</creatorcontrib><creatorcontrib>Gallo, Valentina</creatorcontrib><creatorcontrib>Giacobini, Ezio</creatorcontrib><creatorcontrib>Gold, Gabriel</creatorcontrib><creatorcontrib>Hurst, Samia</creatorcontrib><creatorcontrib>Lönneborg, Anders</creatorcontrib><creatorcontrib>Lovblad, Karl-Olof</creatorcontrib><creatorcontrib>Mattsson, Niklas</creatorcontrib><creatorcontrib>Molinuevo, José-Luis</creatorcontrib><creatorcontrib>Monsch, Andreas U</creatorcontrib><creatorcontrib>Mosimann, Urs</creatorcontrib><creatorcontrib>Padovani, Alessandro</creatorcontrib><creatorcontrib>Picco, Agnese</creatorcontrib><creatorcontrib>Porteri, Corinna</creatorcontrib><creatorcontrib>Ratib, Osman</creatorcontrib><creatorcontrib>Saint-Aubert, Laure</creatorcontrib><creatorcontrib>Scerri, Charles</creatorcontrib><creatorcontrib>Scheltens, Philip</creatorcontrib><creatorcontrib>Schott, Jonathan M</creatorcontrib><creatorcontrib>Sonni, Ida</creatorcontrib><creatorcontrib>Teipel, Stefan</creatorcontrib><creatorcontrib>Vineis, Paolo</creatorcontrib><creatorcontrib>Visser, Pieter Jelle</creatorcontrib><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Winblad, Bengt</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><collection>SWEPUB Lunds universitet</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Frisoni, Giovanni B</au><au>Boccardi, Marina</au><au>Barkhof, Frederik</au><au>Blennow, Kaj</au><au>Cappa, Stefano</au><au>Chiotis, Konstantinos</au><au>Démonet, Jean-Francois</au><au>Garibotto, Valentina</au><au>Giannakopoulos, Panteleimon</au><au>Gietl, Anton</au><au>Hansson, Oskar</au><au>Herholz, Karl</au><au>Jack, Clifford R</au><au>Nobili, Flavio</au><au>Nordberg, Agneta</au><au>Snyder, Heather M</au><au>Ten Kate, Mara</au><au>Varrone, Andrea</au><au>Albanese, Emiliano</au><au>Becker, Stefanie</au><au>Bossuyt, Patrick</au><au>Carrillo, Maria C</au><au>Cerami, Chiara</au><au>Dubois, Bruno</au><au>Gallo, Valentina</au><au>Giacobini, Ezio</au><au>Gold, Gabriel</au><au>Hurst, Samia</au><au>Lönneborg, Anders</au><au>Lovblad, Karl-Olof</au><au>Mattsson, Niklas</au><au>Molinuevo, José-Luis</au><au>Monsch, Andreas U</au><au>Mosimann, Urs</au><au>Padovani, Alessandro</au><au>Picco, Agnese</au><au>Porteri, Corinna</au><au>Ratib, Osman</au><au>Saint-Aubert, Laure</au><au>Scerri, Charles</au><au>Scheltens, Philip</au><au>Schott, Jonathan M</au><au>Sonni, Ida</au><au>Teipel, Stefan</au><au>Vineis, Paolo</au><au>Visser, Pieter Jelle</au><au>Yasui, Yutaka</au><au>Winblad, Bengt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>16</volume><issue>8</issue><spage>661</spage><epage>676</epage><pages>661-676</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><abstract>The diagnosis of Alzheimer's disease can be improved by the use of biological measures. Biomarkers of functional impairment, neuronal loss, and protein deposition that can be assessed by neuroimaging (ie, MRI and PET) or CSF analysis are increasingly being used to diagnose Alzheimer's disease in research studies and specialist clinical settings. However, the validation of the clinical usefulness of these biomarkers is incomplete, and that is hampering reimbursement for these tests by health insurance providers, their widespread clinical implementation, and improvements in quality of health care. We have developed a strategic five-phase roadmap to foster the clinical validation of biomarkers in Alzheimer's disease, adapted from the approach for cancer biomarkers. Sufficient evidence of analytical validity (phase 1 of a structured framework adapted from oncology) is available for all biomarkers, but their clinical validity (phases 2 and 3) and clinical utility (phases 4 and 5) are incomplete. To complete these phases, research priorities include the standardisation of the readout of these assays and thresholds for normality, the evaluation of their performance in detecting early disease, the development of diagnostic algorithms comprising combinations of biomarkers, and the development of clinical guidelines for the use of biomarkers in qualified memory clinics.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28721928</pmid><doi>10.1016/S1474-4422(17)30159-X</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1474-4422
ispartof Lancet neurology, 2017-08, Vol.16 (8), p.661-676
issn 1474-4422
1474-4465
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_495341
source MEDLINE; Elsevier ScienceDirect Journals
subjects 1984
1992
5-phase development framework
Algorithms
Alzheimer Disease - diagnosis
Alzheimer's disease
amyloid pet
association workgroups
Biomarkers
Brain research
Cancer
Cerebrospinal fluid
cerebrospinal-fluid biomarkers
clinical
Clinical Medicine
Clinical trials
Cognitive ability
Dementia
Diagnosis
Early Diagnosis
heltens p
Humans
Interdisciplinary aspects
journal of neurology neurosurgery and psychiatry
khann g
Klinisk medicin
Magnetic resonance imaging
Medical and Health Sciences
Medical diagnosis
Medical imaging
Medicin och hälsovetenskap
mild cognitive impairment
national institute
Neurodegenerative diseases
Neuroimaging
Neurologi
Neurology
Neurosciences & Neurology
p939
p967
Physicians
Positron emission tomography
Regulatory approval
Task forces
task-force
tau pathology
v34
v55
Validation Studies as Topic
Validity
title Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T23%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Strategic%20roadmap%20for%20an%20early%20diagnosis%20of%20Alzheimer's%20disease%20based%20on%20biomarkers&rft.jtitle=Lancet%20neurology&rft.au=Frisoni,%20Giovanni%20B&rft.date=2017-08-01&rft.volume=16&rft.issue=8&rft.spage=661&rft.epage=676&rft.pages=661-676&rft.issn=1474-4422&rft.eissn=1474-4465&rft_id=info:doi/10.1016/S1474-4422(17)30159-X&rft_dat=%3Cproquest_swepu%3E1920395361%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1919451405&rft_id=info:pmid/28721928&rft_els_id=S147444221730159X&rfr_iscdi=true